Candida News and Research

RSS

MSU researchers uncover how superfungus Candida auris evades antifungal drugs

A groundbreaking study from Michigan State University (MSU), recently published in Nature Communications, has revealed how the multidrug-resistant superfungus Candida auris uniquely reconstructs its cell wall to survive antifungal treatments.

15 Jul 2025

Understanding the interconnected roles of microbial, metabolic, and immune biomarkers in IBD

Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory condition of the gastrointestinal tract with a rising global burden.

19 Jun 2025

UC Davis researchers call for global action on antifungal resistance

UC Davis infectious diseases experts George Thompson and Angel Desai are raising the alarm about the role new pesticides can play in building resistance to antifungal medical treatments.

9 Jun 2025

Climate models predict spread of deadly Aspergillus pathogens

Climate change is projected to shift the global distribution of key Aspergillus species, with northward movement of suitable habitats and changing risks for human health and agriculture. Advanced modelling reveals significant implications for food security and clinical fungal infections.

26 May 2025

New clues on how cells protect chromosome ends during division

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy.

17 Apr 2025

How your skin’s microbes shape immunity, inflammation, and chronic skin disease

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your lifespan. This review explains how disruptions in this microbiome-immune dialogue can lead to eczema, psoriasis, or acne.

2 Apr 2025

WHO releases first reports on shortages in fungal disease treatments and diagnostics

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps.

2 Apr 2025

Early antibiotic exposure may boost risk of diabetes later in life

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice suggests.

25 Mar 2025

How your diet and probiotics can improve vaccine effectiveness

Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for precision immunization.

23 Mar 2025

New research links early-life microbes to long-term metabolic health

The microbiome shapes development of insulin-producing cells in infancy, leading to long-term changes in metabolism and diabetes risk, new research in mice has found.

6 Mar 2025

Your home is full of mold, but daycares are teeming with yeast—here’s why

Researchers found that daycares have a higher abundance of yeasts, while private houses contain more spore-producing molds, with occupant density and ventilation playing key roles in fungal distribution.

23 Feb 2025

New global guideline for Candida infections sets standards for diagnosis and treatment

Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have published the new global guideline for the diagnosis and treatment of Candida infections.

14 Feb 2025

New project aims to measure nicotine use through sewage

University of California, Merced's Nicotine and Cannabis Policy Center has embarked on an innovative partnership with researchers at the university who track an entire community's health and habits with samples of human sewage.

11 Feb 2025

International travel and health care networks drive Candida auris outbreaks

In just a decade, the drug-resistant fungal pathogen Candida auris (C. auris) has emerged as one of the most formidable threats to health care settings worldwide.

10 Feb 2025

How gut microbiota impacts childhood obesity

Gut microbiota plays a critical role in childhood obesity by influencing energy metabolism, inflammation, and appetite regulation, with emerging therapeutic strategies like probiotics, dietary interventions, and fecal microbiota transplantation showing promise.

21 Jan 2025

Hormonal shifts in menopause redefine women’s microbiome and risks

Research explores how menopause-induced hormonal shifts affect the microbiome, influencing oral, gut, and urogenital health, and highlights the potential of personalized interventions to enhance well-being.

15 Jan 2025

NIH awards $3.96 million to develop combination therapies for superbugs

Gram-negative bacteria pose a serious threat to global health because they can resist multiple antibiotics, making infections difficult to treat, according to the National Institutes of Health.

15 Nov 2024

Scientists develop first durable human lip cell models in the lab

We use our lips to talk, eat, drink, and breathe; they signal our emotions, health, and aesthetic beauty. It takes a complex structure to perform so many roles, so lip problems can be hard to repair effectively. Basic research is essential to improving these treatments, but until now, models using lip cells - which perform differently to other skin cells - have not been available.

4 Nov 2024

Enhanced screening protocols for Candida auris improve hospital infection control

Mount Sinai researchers have enhanced hospital screening protocols for Candida auris, an often-drug-resistant fungal pathogen the Centers for Disease Control and Prevention considers an urgent global health threat.

1 Nov 2024

Brazil-Italy joint lab focuses on Alzheimer’s drug development

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer's disease.

17 Oct 2024